目的观察缓激肽对转化生长因子-β1(TGF-β1)诱导的肺动脉平滑肌细胞(PASMCs)迁移的影响及其可能机制。方法原代培养PASMCs,应用Transwell小室检测缓激肽对PASMCs跨膜迁移能力的影响,同时应用划痕修复实验检测缓激肽对PASMCs横向迁移能力的影响。结果TGF-β1显著增加了跨膜迁移的PASMCs数目(P〈O.05),缓激肽显著减少了PASMCs的跨膜迁移(P〈O.05),而B2受体抑制剂(HOE-140)对缓激肽抑制TGF-β1诱导的PASMCs的跨膜迁移作用无显著改变(P〉0.05)。缓激肽显著降低PASMCs的划痕愈合指数(P〈0.05),而HOE-140对缓激肽抑制TGF-β1诱导的PASMCs的横向迁移能力无显著改变(P〉0.05)。结论缓激肽可以抑制TGF-β1诱导的PASMCs跨膜和横向迁移能力,而这一效应可能不通过缓激肽B2受体介导。
Objective To study the effects of bradykinin (BK) on pulmonary artery smooth muscle cells (PASMCs) migration induced by transforming growth factor-β1 (TGF-β1) and their possible mechanisms. Methods The transmembrane migration of BK on primary PASMCs with TGF-β1 treatment was examined by transwell assay, and the lateral migration of BK on primary PASMCs with TGF-β1 was determined by healing of surface scratch assay. Results TGF-β1 significantly increased the number of PASMCs migrating across the membrane (P 〈 O. 05 ). BK significantly reduced TGF-β1 induced PASMCs transmembrane migration (P〈0.05), which was not prevented by the B2 receptor (B2R) inhibitor HOE-140 (P〉0.05). Furthermore, BK significantly reduced TGF-β1 -induced PASMCs lateral migration (P〈0.05) , while the effect was not blocked by the B2R inhibitor HOE-140 (P 〉 0. 05 ). Conclusion BK can significantly inhibit TGF-β1-induced PASMCs transmembrane and lateral migration. However the inhibitory effects of migration may not be mediated by bradykinin B2 receptor.